Lynx1 Capital Management LP

Holdings History for Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

Symbol: PASG on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 623,704 shares
Security Ownership %: 20%

Shares, Excluding Options vs Price

Value, Excluding Options

LYNX1 CAPITAL MANAGEMENT LP ownership in Passage BIO, Inc. Common Stock, par value $0.0001 per share (PASG)

14 Nov 2025 - LYNX1 CAPITAL MANAGEMENT LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 623,704 shares of Passage BIO, Inc. Common Stock, par value $0.0001 per share (PASG). This represents 20% ownership of the company. In their previous filing dated 14 Feb 2025, Lynx1 Capital Management LP had reported owning 9,256,953 shares, indicating a decrease of +93%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
LYNX1 CAPITAL MANAGEMENT LP	20%	+31%	$243,245	623,704	-8,633,249	-93%	$0.39	13G/A	30 Sep 2025	14 Nov 2025, 14:01
Lynx1 Capital Management LP	15%		$3,054,794	9,256,953			$0.33	13G/A	31 Dec 2024	14 Feb 2025, 09:01

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-1.1%	$0	0	-9,256,953	-100%	$8.03	Q3 2025
30 Jun 2025	1.1%	0%	$3,705,558	9,256,953	0		$0.40	Q2 2025
31 Mar 2025	1.2%	0%	$3,268,630	9,256,953	0		$0.35	Q1 2025
31 Dec 2024	2%	+0.18%	$5,249,618	9,256,953	+829,998	+9.8%	$0.57	Q4 2024
30 Sep 2024	2.1%	+0.84%	$5,898,869	8,426,955	+3,369,326	+67%	$0.70	Q3 2024
30 Jun 2024	1.5%	+0.04%	$4,016,769	5,057,629	+211,758	+4.4%	$0.79	Q2 2024
31 Mar 2024	1.7%	+1.6%	$6,541,926	4,845,871	+4,466,712	+1178%	$1.35	Q1 2024
31 Dec 2023	0.15%	+0.08%	$382,951	379,159	+189,035	+99%	$1.01	Q4 2023
30 Sep 2023	0.08%	-0.43%	$125,102	190,124	-977,219	-84%	$0.66	Q3 2023
30 Jun 2023	0.72%	-1.4%	$1,098,820	1,167,343	-2,240,255	-66%	$0.94	Q2 2023
31 Mar 2023	2.7%	+0.04%	$3,263,457	3,407,598	+51,681	+1.5%	$0.96	Q1 2023
31 Dec 2022	4%	0%	$4,631,165	3,355,917	0		$1.38	Q4 2022
30 Sep 2022		0%	$3,441,000	2,752,422	0		$1.25 ^*	Q3 2022
30 Jun 2022	0.85%	+0.64%	$995,000	421,410	+315,906	+299%	$2.36	Q2 2022
31 Mar 2022	0.3%	+0.3%	$327,000	105,504	+105,504	NEW	$3.10	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.